Loading
TC
TearLab Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Karpecki Paul, was filed 30 Nov 2018.
TearLab Corp: what insiders have been doing
Every trade that managers of TearLab Corp disclose to SEC (Form 4) is tracked on this page. No insider at TearLab Corp has published a filing in the past twelve months. The most recent one dates from 10 July 2020.
Looking back to 2016, when coverage begins, insiders filed 14 purchases and 7 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
30
Thresholds
n/a
Buy Volume
€139,120
14 ops. · all time
Sell Volume
€967,171
7 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
Revenue20.2M
Gross profit12.7M63% margin
Net income-4.8M-23.9% margin
Last declaration on 10 July 2020
Declarations30 total
20,140 shares@ US$0.058611.0% of flowCommon StockSEC:0001493152-20-013071:0
130,813 shares@ US$0.058671.5% of flowCommon StockSEC:0001493152-20-013071:1
32,000 shares@ US$0.058617.5% of flowCommon StockSEC:0001493152-20-013071:2
8,833 shares@ US$0.0586100.0% of flowCommon StockSEC:0001493152-20-012956:0
500 shares@ US$0.0586100.0% of flowCommon StockSEC:0001493152-20-012961:0
102,200 shares@ US$0.0586100.0% of flowCommon StockSEC:0001493152-20-012959:0
22,540 shares@ US$0.0586100.0% of flowCommon StockSEC:0001493152-20-012958:0
14,778 shares@ US$0.058671.1% of flowCommon StockSEC:0001493152-20-012960:0
6,000 shares@ US$0.058628.9% of flowCommon StockSEC:0001493152-20-012960:1
15,049 shares@ US$0.109.1% of flowCommon StockSEC:0001493152-18-016901:0
Canonical exit: 13 Feb 2019 (T+90)
5,000 shares@ US$0.1053.2% of flowCommon StockSEC:0001493152-18-016901:1
Canonical exit: 13 Feb 2019 (T+90)
45,000 shares@ US$0.1130.1% of flowCommon StockSEC:0001493152-18-016901:2
Canonical exit: 13 Feb 2019 (T+90)
10,604 shares@ US$0.106.4% of flowCommon StockSEC:0001493152-18-016901:3
Canonical exit: 14 Feb 2019 (T+90)
24,347 shares@ US$0.1014.7% of flowCommon StockSEC:0001493152-18-016901:4
Canonical exit: 17 Feb 2019 (T+90)
50,000 shares@ US$3.3521.7% of flowCommon StockSEC:0001535264-17-000037:2
25,000 shares@ US$3.2410.5% of flowCommon StockSEC:0001535264-17-000037:3
100,000 shares@ US$3.1741.0% of flowCommon StockSEC:0001535264-17-000037:4
6,239 shares@ US$3.142.5% of flowCommon StockSEC:0001535264-17-000037:5
57,000 shares@ US$3.2924.3% of flowCommon StockSEC:0001535264-17-000037:6
39,435 shares@ US$3.05Common StockSEC:0001535264-17-000037:0
50,000 shares@ US$3.11Common StockSEC:0001535264-17-000037:1
20,432 shares@ US$0.7710.8% of flowCommon StockSEC:0001493152-16-010452:0
Canonical exit: 25 Aug 2016 (T+90)
39,254 shares@ US$0.780921.2% of flowCommon StockSEC:0001493152-16-010452:1
Canonical exit: 29 Aug 2016 (T+90)
62,100 shares@ US$0.739931.8% of flowCommon StockSEC:0001493152-16-010349:0
Canonical exit: 22 Aug 2016 (T+90)
29,400 shares@ US$0.769115.6% of flowCommon StockSEC:0001493152-16-010349:1
Canonical exit: 23 Aug 2016 (T+90)
25 of 30 declarations
About TearLab Corp
TearLab Corp is a company focused on developing diagnostic technologies for eye diseases. It primarily concentrates on tear quality testing.
